Armira completed the acquisition of a minority stake in Osypka.

Armira, a German investment holding, completed the acquisition of a minority stake in Osypka, a German MedTech company providing mission-critical cardio products and services for neuromodulation solutions. Financial terms were not disclosed. "We are excited to announce that Osypka has entered into a strategic partnership with Armira, a leading German investment holding company. With Armira’s long-term support, we will strengthen our global presence, scale innovation, and expand production capacity — continuing our mission to deliver cutting edge solutions in medical technology."